Skip to content

Novavax

US · NVAX #2865 by market cap Listed 1970
11.22 -0.10 -0.88%
Live - 5344 symbols - heartbeat 77s ago · 2026-10-08 08:39
Pre-market 11.06 -1.43%
After-hours 11.16 -0.53%
Overnight 11.03 -1.69%
Market cap
1.85B
P/B
-9.71
EPS
2.58
Reader sentiment Are you bullish or bearish on NVAX?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Mixed / stable
  • The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
  • Total institutional ownership (as a % of shares) was little changed.

Institutional ownership

Held by institutions
71.42% -0.03pp
Institutions
308 +1
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund39.68%
Hedge Fund21.99%
Public Company8.44%
Private Company0.86%
Individual/Insider0.80%
Government Pension Fund0.35%
Other27.78%

Top holders as of 2026-06-30

Shah Capital Management, Inc 8.59% · 14.17M sh
BlackRock 8.46% · 13.95M sh
State Street Global Advisors 7.12% · 11.74M sh
Vanguard Capital Management, LLC 5.06% · 8.34M sh
Vanguard Portfolio Management, LLC 4.61% · 7.61M sh
Sanofi 4.17% · 6.88M sh
D. E. Shaw & Co., L.P. 3.43% · 5.65M sh
Geode Capital Management, LLC 2.55% · 4.21M sh
Two Sigma Investments, LP 2.48% · 4.09M sh
Coatue Management 2.33% · 3.84M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 41 buys · 6 sells

NameRoleStake
John Jacobs Chief Executive Officer 0.19%
Elaine O'Hara Chief Strategy Officer 0.08%
James Kelly Chief Financial Officer 0.08%
John Trizzino Executive VP, Chief Commercial Officer & Chief Business Officer 0.07%
Mark Casey Executive Vice President 0.05%
David Mott Independent Director 0.05%
Richard Douglas Independent Director 0.04%
Gregg Alton Independent Director 0.03%
Richard Rodgers Independent Director 0.03%
Margaret McGlynn Independent Director 0.03%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-06-19 David Mott Independent Director Derivative Exercise and Retained +18,880 --
2026-06-19 Richard Douglas Independent Director Derivative Exercise and Retained +18,880 --
2026-06-19 Margaret McGlynn Independent Director Derivative Exercise and Retained +18,880 --
2026-06-19 Gregg Alton Independent Director Derivative Exercise and Retained +18,880 --
2026-06-19 Rachel King Independent Director Derivative Exercise and Retained +18,880 --
2026-06-19 Richard Rodgers Independent Director Derivative Exercise and Retained +18,880 --
2026-06-17 David Mott Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 David Mott Independent Director Other Derivative Acquisition +21,270 $9.13
2026-06-17 Richard Douglas Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 Richard Douglas Independent Director Other Derivative Acquisition +21,270 $9.13
2026-06-17 Margaret McGlynn Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 Margaret McGlynn Independent Director Other Derivative Acquisition +21,270 $9.13
2026-06-17 Gregg Alton Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 Gregg Alton Independent Director Other Derivative Acquisition +21,270 $9.13
2026-06-17 Rachel King Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 Rachel King Independent Director Other Derivative Acquisition +21,270 $9.13
2026-06-17 Richard Rodgers Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 Richard Rodgers Independent Director Other Derivative Acquisition +21,270 $9.13
2026-06-17 John Shiver Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 John Shiver Independent Director Other Derivative Acquisition +21,270 $9.13

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 08:39:33 · For reference only, not investment advice and not tailored to your situation.